Linda Lennox | Vice President, Investor Relations |
Bill Heiden | President and Chief Executive Officer |
Nik Grund | Chief Commercial Officer |
Julie Krop | Chief Medical Officer |
Ted Myles | Chief Financial Officer |
Ami Fadia | SVB Leerink |
David Buck | B. Riley FBR |
Eun Yang | Jefferies |
Jessica Fye | JPMorgan |
Serge Belanger | Needham & Company |
Good morning. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the AMAG Pharmaceuticals 2018 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.